Geode Capital Management Portfolio holdings
Geode Capital Management, founded in 2001 and based in Boston, Massachusetts, is a prominent institutional asset management firm known for its expertise in low-cost, systematic index investing. Originally established to manage internal index funds for Fidelity Investments, Geode became an independent entity while retaining a close relationship with Fidelity, focusing on passive investment strategies that track major market indices. The firm oversees hundreds of billions in assets, offering a range of mutual funds and separately managed accounts primarily for institutional clients, such as pension funds and endowments, with an emphasis on minimizing costs and maximizing efficiency. Geode’s disciplined, quantitative approach and avoidance of active management have made it a key player in the rise of index-based investing.
Top Buys
| 1 |
Microsoft
MSFT
|
+$974M |
| 2 |
Apple
AAPL
|
+$780M |
| 3 |
Amazon
AMZN
|
+$768M |
| 4 |
Kenvue
KVUE
|
+$659M |
| 5 |
Blackstone
BX
|
+$597M |
Top Sells
| 1 |
Johnson & Johnson
JNJ
|
+$413M |
| 2 |
Texas Instruments
TXN
|
+$219M |
| 3 |
LSI
Life Storage, Inc.
LSI
|
+$202M |
| 4 |
Pfizer
PFE
|
+$192M |
| 5 |
BKI
Black Knight, Inc. Common Stock
BKI
|
+$145M |
Sector Composition
| 1 | Technology | 27.72% |
| 2 | Healthcare | 13.06% |
| 3 | Financials | 12.45% |
| 4 | Consumer Discretionary | 10.84% |
| 5 | Industrials | 8.9% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
3876
Solid Biosciences
SLDB
$408M
| $258K | ﹤0.01% |
102,513
+13,254
| +15% | +$33.4K |
|
|
EXPR
3877
DELISTED
Express, Inc.
EXPR
| $258K | ﹤0.01% |
28,661
-206
| -0.7% | -$1.86K |
|
3878
Capital Southwest
CSWC
$1.26B
| $258K | ﹤0.01% |
11,251
| – | – |
|
3879
Safety Shot
SHOT
$85.5M
| $258K | ﹤0.01% |
172,231
+63,033
| +58% | +$94.3K |
|
3880
TherapeuticsMD
TXMD
$12.7M
| $256K | ﹤0.01% |
84,788
+3,007
| +4% | +$9.08K |
|
3881
Matinas BioPharma
MTNB
$9M
| $255K | ﹤0.01% |
39,210
+31
| +0.1% | +$202 |
|
3882
Research Frontiers
REFR
$43.4M
| $254K | ﹤0.01% |
235,447
+20,772
| +10% | +$22.4K |
|
|
EVLO
3883
DELISTED
Evelo Biosciences, Inc. Common Stock
EVLO
| $254K | ﹤0.01% |
64,823
+35,751
| +123% | +$140K |
|
3884
HCW Biologics
HCWB
$7.21M
| $253K | ﹤0.01% |
3,313
+37
| +1% | +$2.83K |
|
3885
CF Bankshares
CFBK
$163M
| $253K | ﹤0.01% |
14,947
+213
| +1% | +$3.61K |
|
3886
Data I/O
DAIO
$32.9M
| $253K | ﹤0.01% |
66,276
+15,541
| +31% | +$59.2K |
|
3887
Cognition Therapeutics
CGTX
$221M
| $252K | ﹤0.01% |
174,798
-1,700
| -1% | -$2.45K |
|
3888
Corbus Pharmaceuticals
CRBP
$118M
| $251K | ﹤0.01% |
37,181
+4,316
| +13% | +$29.1K |
|
3889
Team
TISI
$84.2M
| $250K | ﹤0.01% |
35,934
+3,574
| +11% | +$24.8K |
|
3890
Immix Biopharma
IMMX
$63.1M
| $250K | ﹤0.01% |
73,022
+12,696
| +21% | +$43.4K |
|
|
IDEX
3891
DELISTED
Ideanomics, Inc. Common Stock
IDEX
| $250K | ﹤0.01% |
102,676
+96,275
| +1,504% | +$234K |
|
|
XELA
3892
DELISTED
Exela Technologies, Inc. Common Stock
XELA
| $250K | ﹤0.01% |
59,108
+8,284
| +16% | +$35K |
|
|
OPRA
3893
Opera Ltd
OPRA
$1.76B
| $249K | ﹤0.01% |
22,109
+1,779
| +9% | +$20K |
|
3894
Neurogene
NGNE
$265M
| $248K | ﹤0.01% |
15,721
+668
| +4% | +$10.6K |
|
3895
SunCar Technology Group
SDA
$273M
| $247K | ﹤0.01% |
23,318
+4,278
| +22% | +$45.4K |
|
|
FSRX
3896
DELISTED
FinServ Acquisition Corp. II Class A Common Stock
FSRX
| $247K | ﹤0.01% |
23,391
| – | – |
|
3897
Rani Therapeutics
RANI
$23.3M
| $247K | ﹤0.01% |
113,629
+16,444
| +17% | +$35.8K |
|
|
AISP
3898
Airship AI Holdings
AISP
$148M
| $247K | ﹤0.01% |
22,411
| – | – |
|
3899
TH International
THCH
$80.7M
| $247K | ﹤0.01% |
27,238
+4,297
| +19% | +$38.9K |
|
3900
Quince Therapeutics
QNCX
$86.5M
| $246K | ﹤0.01% |
219,603
+32,441
| +17% | +$36.3K |
|